STAT Plus: Astellas treatment offers new hope to a devastated rare disease community
The Readout
Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Here’s our web archive of the free email newsletter delivered daily, Monday through Friday.
Latest
STAT Plus: The biotech news you need to read today
STAT Plus: FDA revisits a rare cancer treatment it rejected a few months ago
STAT Plus: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share price
STAT Plus: Are analysts too quick to gloss over Lilly’s liver case?
UCB to acquire maker of antibody treatments for autoimmune diseases
STAT Plus: Axsome wins FDA nod for Alzheimer’s agitation
STAT Plus: Five-way obesity drug is super effective — in mice
All Coverage
